Press Releases
 
Home Page
 
Letter From The Chairman
 
Sponsor & Exhibitors
 

Committees

 
General Information
 
Tentative Time Table
 
Programme
 
Accommodation
 
Accompanying Persons Programme
 
Post Congress Tours
 
Registration Form
  
Information about sessions in German


THURSDAY, DECEMBER 7, 2000 FRIDAY, DECEMBER 8, 2000 SATURDAY, DECEMBER 9, 2000 POSTERS
FRIDAY-SATURDAY, DECEMBER 8-9, 2000

     

FRIDAY-SATURDAY, DECEMBER 8-9, 2000
Board No.   
AN AUDIT OF THE TIMELENESS AND APPROPRIATENESS OF REFERRALS TO A HOSPITAL SPECIALIST PALLIATIVE CARE TEAM 
D. Edwards, P. Langstone, N. Barrows, London, UK
INVASIVE TREATMENTS PERFORMED DURING "HOSPICE AT HOME" SERVICE IN NORTHERN ISRAEL - RETROSPECTIVE SURVEY.
D. Steinmetz, R. Borovik, N. Sade, W. Rubinstein, R. Oppenheim, M. Steiner, A. Almani, Kiryat Tivon, , Israel
ARE WE MEETING PATIENT'S DESIRED PLACE OF DEATH, IF KNOWN?
L. Kerr, K. Sherry, M. Tadjali, Air, UK
DO DOCTORS IN A PALLIATIVE CARE SETTING RECOGNISE DEPRESSIVE SYMPTOMS IN PATIENTS WITH INCURABLE CANCER?   
L. Pedersen, M. Groenvold, A. Stromgren, P. Sjogren, Copenhagen, Denmark
A PROSPECTIVE AUDIT OF OPIOID ADVERSE EFFECTS IN PATIENTS ADMITTED TO A SPECIALIST PALLIATIVE CARE UNIT 
C. Ross, K. Boyd, Edinburgh, UK
MEDICAL END OF LIFE DECISIONS IN TERMINAL CANCER PATIENTS
A. Van Leeuwen, E. Voogt, A. Van Der Heide, K. Van Der Rijt, A. Visser, P. Van Der Maas, Rotterdam, The Netherlands
MEDROXYPROGESTERONE ACETATE (MPA) IN THE CONTROL OF ANOREXIA IN TERMINALLY CANCER PATIENTS
G. Moruzzi, A. Di Mari, R.D. Respini, D.U. Dipasquale, T.P. Tralongo, Siracusa, Italy
DEXAMETHASONE ADMINISTRATION IN THE LAST 14 DAYS OF LIFE IN PATIENTS WITH PRIMARY BRAIN TUMOURS
J. Wand, C. Campbell, Caterham, Caterham, UK
EFFICACY OF LEVOMEPROMAZINE FOR REFRACTORY EMESIS IN 45 ADVANCED CANCER PATIENTS
J. Eisenchlas, N. Garrigue, M. Junin, G.G. De Simone, Buenos Aires, Argentina
10  A PHASE 2 STUDY OF NEBULISED MORPHINE-6-GLUCURONIDE IN PATIENTS WITH CANCER-RELATED BREATHLESSNESS
C. Quigley, S. Joel, M. Slevin, London, UK
11  CAN THE USE OF ARM EXERCISE IN PATIENTS WITH CANCER AID THE RESEARCH OF NEW THERAPIES FOR BREATHLESSNESS?
J. Edgecombe, A. Wilcock, V. Crosby, H. Pavis, D. Carr, C. Manderson, D. Clarke, B. Cooper, A.E. Tattersfield, Glasgow, UK
12  TERMINAL CANCER PATIENTS OF WORKING AGE: HOME CARE PLANNING
D. Cattaneo, A. Grossi, L. Rebosio, M. Comi, Italy
13  ACUPUNCTURE FOR THE RELIEF OF BREATHLESSNESS IN HOSPICE PATIENTS A PRELIMINARY REPORT OF A RANDOMISED CONTROLLED TRIAL WITH PLACEBO AND DOUBLE BLINDING
C.M. Wu, J. Wong, C. Kwan, T. Lai, C. Fung, H. Law, J. Lee, Hong Kong, China
14  SYSTEMATIC REVIEW ON THE EFFECTS OF HIGH-DOSE PROGESTINS FOR THE TREATMENT OF CANCER ANOREXIA-CACHEXIA SYNDROME
M. Maltoni, E. Scarpi, O. Nanni, D. Rossi, P. Serra, D. Amadori, Forli, Italy
15  THE EXPERIENCE OF BREATHLESSNESS: A QUALITATIVE APPROACH
S. Silvester, S. Booth, C. Todd, Cambridge, UK
16  LOCAL IRRADIATION OF PATIENTS WITH BONE METASTASES AS PAIN TREATMENT AND PREVENTION OF SPINAL CORD COMPRESSION
P. Milecki, G. Stryczynska, M. Baczyk, J. Luczak, Poland
17  TREATMENT OF MALIGNANT GASTROINTESTINAL OBSTRUCTION WITH OCTREOTIDE
I. Strohscheer, D. Huhn, Berlin, Germany
18  QUALITY OF CARE OF TERMINAL PATIENTS AT A PALLIATIVE CARE UNIT: EVALUATION OF DYSPNEA MANAGEMENT PROCEDURES (A PILOT STUDY)
G. Van Den Eynden, B. Van Den Eynden, P. Van Royen, J. Denekens, Belgium
19  METHYLPHENIDATE FOR DEPRESSION IN ADVANCED CANCER
J. Homsi, D. Walsh, K. Nelson, N. Sarhill, S.B. Legrand, M. Davis, USA
20  EVALUATION OF NUTRITIONAL STATUS IN ADVANCED CANCER
N. Sarhill, K. Nelson, D. Walsh, S. Komurcu, J. Homsi, M. Davis, S. Legrand, USA
21  HOW TO STUDY PATIENTS WITH CANCER ANOREXIA/CACHEXIA SYNDROME (CCS): "WORK IN PROGRESS REPORT" FROM A PLACEBO-CONTROLLED PHASE III TRIAL WITH EMPHASIS ON THE DIFFICULTIES TO DEFINE AN ADEQUATE PATIENT
F. Strasser, M. Schnelle, T. Kuechler, M. Reif, T. Cerny, M. Robbins, Houston, TX, Bristol, UK, USA
22  PALLIATIVE CARE - CURRENT SITUATION IN GERMANY
R. Sabatowski, L. Radbruch, G. Loick, F. Nauck, E. Klaschik, Koeln, Germany
23  COST OF PAIN TREATMENT AND PALLIATIVE CARE: PROBLEM OR SOLUTION?
P.M. Ingelmo, O. Gomez, A. Scheucher, C. De Paz, O. Albornoz, O. Altalef, J. Meyer, B. Stegmuller, E. Prieto, C. Bidolegui, Buenos Aires, Argentina
24  EVALUATION OF THE REFERRALS TO A TRANSMURAL PALLIATIVE CARE TEAM IN MAASTRICHT (THE NETHERLANDS)
A. Courtens, V. Schrijnemaekers, C. Spreeuwenberg, I. Proot, The Netherlands
25  FAMILY SATISFACTION WITH A HOSPITAL BASED PALLIATIVE CARE SERVICE: A RANDOMISED CONTROLLED TRIAL
K. Done, G. Hanks, U.K.M. Robbins, U.K.K. Baxter, U.K.C. Bidgood, U.K.F. Corfe, U.K.K. Forbes, U.K.H. Morgan, U.K.T. Peters, U.K.D. Sharp, U.K.J. Sykes, Bristol, UK
26  COMMUNICATION DURING TRANSFER OF PALLIATIVE PATIENTS: A PROBLEM-ORIENTED ANALYSIS
D. Schrijvers, M. Comyn, P. Demeulenaere, L. De Wulf, W. Maeckelberghe, B. Van Den Eynden, N. Van Genechten, A. Verhoeven, K. Willems, Wilrijk, Belgium
27  PAIN THERAPY AND QUALITY OF LIFE OF CHRONIC PATIENTS A REPRESENTATIVE STUDY
W. Pipam, R. Likar, J. Klocker, L. Ruppacher, H. Janig, G. Bernatzky, R. Sittl, Klagenfurt, Austria
28  DIFFERENCES IN PATIENT REFERRAL TO A PALLIATIVE CARE SERVICE UNDER AND OVER 70
F. de Conno, R. Boffi, C. Brunelli, C. Panzeri, Milan, Italy
29  DOES HOSPICE CARE IMPROVE THE PSYCHOLOGICAL CARE OF PATIENTS WITH ADVANCED CANCER, AND/OR THEIR FAMILIES/CARERS WHEN COMPARED WITH CONVENTIONAL SERVICES?
H. Cameron, Cheadle, UK
30  THE DEVELOPMENT OF THE PALLIATIVE CARE NETWORK IN BERLIN 1995 - 2000   
C.H. Mueller-Busch, T. Schindler, I. Strohscheer, Berlin, Germany
31  A RANDOMISED CONTROLLED TRIAL TO EVALUATE THE ROLE OF REFLEXOLOGY IN ADVANCED CANCER PATIENTS: RESULTS OF A PILOT STUDY
C. Ross, J. Hamilton, G. Macrae, C. Docherty, K. Lockhart-Wood, M.A.C. Cornbleet, Edinburgh, UK
32  A NETWORK OF PALLIATIVE CARE CONSULTANTS IN ANTWERP: A HELPLINGE FOR GENERAL PRACTITIONERS   
I. Hermann, B. Van Den Eynden, P. Demeulenaere, P. Van Royen, J. Denekens, Belgium
33  THE HISTORY OF A RESEARCH IN PALLIATIVE CARE: THE EXAMPLE OF A STUDY LOOKING AT DETERMINANTS OF THE PALLIATIVE CARE SETTING   
B. Van Den Eynden, I. Hermann, P. Van Royen, D. Schrijvers, R. Maes, A. Verhoeven, K. Herweyers, Mortsel, Belgium
34 INFLUENCE OF SOCIO-DEMOGRAPHIC AND DIAGNOSTIC FACTORS ON HOME CANCER DEATHS IN GENEVA: A POPULATION-BASED STUDY.
T. Huber-Gieseke, C. Bouchardy, O. Huber, P. Chastonay, C.H. Rapin, Geneva, Switzerland
35  HOME CARE BERLIN - PALLIATIVE CARE OF TERMINALLY ILL CANCER PATIENTS  
A. Rieger, T. Schindler, S. Woskanjan, Berlin, Germany
36  A "PALLIATIVE CARE COUNSELLING SERVICE FOR GENERAL PRACTITIONERS" (PCCS) - RESULTS OF THE FIRST YEAR EXPERIENCES 
T. Schindler, S. Woskanjan, H.H. Abholz, Berlin, Germany
37  THE ONCOLOGIC PAIN THERAPEUTICS IN MADEIRA ISLAND
D. Correia, R. Silva, T. Ferreira, D. Freitas, L.F. Fernandes, G. Bebiano, Funchal - Madeira, Portugal
38  WWW.SPORTELLODOLORE.NET: A WEB SITE TO IMPROVE THE COOPERATION BETWEEN PATIENTS, CAREGIVERS AND SPECIALIZED HOSPITAL STAFF FOR OPTIMIZING THE QUALITY OF PALLIATIVE CARE 
A. De Luca, F. Vignotto, M. Maritano, Torin, Italy
39  CATPAL. CATALONIAN MULTICENTER GROUP OF RESEARCH IN PALLIATIVE CARE. DESCRIPTION AND FIRST RESULTS 
A. Tuca, X. Gomez-Batiste, Barcelona, Spain
40  CLINICAL VALIDATION OF A SPANISH VERSION OF THE BRIEF PAIN INVENTORY IN CANCER PAIN PATIENTS 
J.M. Nunez Olarte, C. Muriel, A. Gracia, C. Barutell, R. Galvez, E. Gonzalez, F. Gili, M. Gomez, J. Carulla, X. Gomez-Batiste, L. Aliaga, X. Badia, Madrid, Spain
41  MIDOS - VALIDATION OF A MINIMAL DOCUMENTATION SYSTEM FOR PALLIATIVE CARE PATIENTS  
L. Radbruch, R. Sabatowski, G. Loick, S. Grond, K.A. Lehmann, Germany
42  MIDOS - AN ELECTRONIC DATABASE FOR THE PALLIATIVE CARE UNIT 
G. Loick, L. Radbruch, R. Sabatowski, F. Elsner, Koeln, Germany
43  WHICH FACTORS PREDICT DEPRESSION IN TERMINALLY ILL PATIENTS? 
M. Lloyd-Williams, Leicester , UK
44  RESEARCH ON GLOBAL NEEDS AND PSYCHOLOGICAL DISTRESS EVALUATION IN ADVANCED AND TERMINAL CANCER PATIENTS HOME CARE
E. Cazzaniga, L. Epifani, L. Rebosio, L. Valera, M. Comi, Italy
45  INDIVIDUAL GOALS AS OUTCOME-MEASUREMENT IN TERMINALLY ILL PATIENTS: THE DAGOBERD- INSTRUMENT 
S. Eychmueller, P. Glare, St-Gallen, Switzerland
46  PREDICTORS OF PAIN CONTROL IN TERMINAL CANCER PATIENTS ADMITTED TO AN OUTPATIENT MULTIDISCIPLINARY CLINIC AND TERTIARY PALLIATIVE CARE UNIT   
 A. Vigano, C.M. Neumann, P. Lawlor, H. Quan, J. Hanson, E. Bruera, Edmonton, Albert, Canada
47  MEASUREMENT OF FATIGUE IN PALLIATIVE CARE   
H. Knobel, J.H. Loge, S. Kaasa, Trondheim, Norway
48  ASSESSMENT OF INTESTINAL SIDE EFFECTS AFTER PELVIC RADIOTHERAPY   
A. Bye, S. Kaasa, Bekkestua, Norway
49  QUALITY OF LIFE ASSESSMENT IN PALLIATIVE CARE: METHODOLOGICAL AND ETHICAL ISSUES   
M. Couillot, M.T. Gatt, Bobigny, France
50  SYMPTOM CONTROL GUIDELINES FOR GENERAL PRACTITIONERS IN THE WEST MIDLANDS: ARE THEY USED AND ARE THEY USEFUL?   
C. Faull, C. Hirsch, G. Harris, Birmingham, UK
51  FACTORS AFFECTING GRIEF REACTIONS IN CLOSE FAMILY MEMBERS TO INDIVIDUALS WHO HAVE DIED OF CANCER   G.I. Ringdal, M.S. Jordhoy, K. Ringdal, S. Kaasa, Trondheim, Norway
52  ASSESSING QUALITY OF LIFE IN TERMINAL HEART FAILURE   
D.L. Willems, A. Hak, F. Leurs, Amsterdam, The Netherlands
53  THE USE AND EFFECTIVENESS OF ULTRASOUND SCANNING WITHIN A HOSPICE   
J. Graham, J. Edgecombe, M. Todd, J. Welsh, Glasgow, UK
54  INCIDENT PAIN IN ADVANCED CANCER   
N. Sarhill, K. Nelson, D. Walsh, T. Gutgsell, D. Zhukovsky, Cleveland, OH, USA
55  HOW FREQUENTLY SHOULD A MULTIDIMENSIONAL SYMPTOM ASSESSMENT TOOL BE ADMINISTERED TO TERMINAL CANCER PATIENTS ADMITTED TO A TERTIARY PALLIATIVE CARE UNIT (TPCU)?
C.M. Neumann, A. Vigano, J. Hanson, P. Lawlor, H. Quan, B. Comm, E. Bruera, Edmonton, Alberta, Canada
56  PRELIMINARY INVESTIGATION OF THE PREVALENCE OF NEUROPATHIC PAIN IN DIFFERENT NEOPLASMS.   
G. Galeazzi, A. Caraceni, E. Zecca, C. Martini, F. de Conno, Milan, Italy
57  INTERDISCIPLINARY PALLIATIVE CARE PROGRAMME OF THE SPANISH ASSOCIATION AGAINST CANCER (AECC)   
S. Sobrino, A. Erviti, T. Tojar, A.M. Martinez, J.L. Nunez, A. Fornos, E. Diaz, Spain
58  INTERDISCIPLINARY PALLIATIVE CARE PROGRAMME OF THE SPANISH ASSOCIATION AGAINST CANCER (AECC) DOMICILIARY CARE OF TERMINAL CANCER PATIENTS.   
S. Sobrino, A. Erviti, T. Topjar, A.M. Martinez, J.L. Nunez, A. Fornos, E. Diaz, Madrid, Spain
59  EXPERIMENTAL APPROACH TOWARDS ASSESSING QUALITY OF LIFE OF OLD-OLD PATIENTS WITH DEMENTIA  
M. Kojer, M. Schmidl, E. Greimel, J. Sigle, M. Eisemann, F. Porzsolt, Vienna, Austria
60  QUALITY OF LIFE MEASUREMENTS CAN EVALUATE THERAPEUTIC INTERVENTIONS IF THEY ARE VISUALISED   
B. Axelsson, Ostersund, Sweden
61  VULNERABILITY TO PSYCHOLOGICAL DISTRESS IN CANCER PATIENTS (PTS) RECEIVING CHEMOTHERAPY (CT)   
S.C. Bonicatto, M.A. Dew, J.J. Soria, Buenos Aires, Argentina
62  DIMENSIONS OF PATIENT CENTERED QUALITY IN PALLIATIVE CARE  
K. Heimerl, A. Heller, I. Berlach-Pobitzer, Vienna, Austria
63  PSYCHOSOCIAL CARE FOR TERMINAL CANCER PATIENTS: A FOLLOW-UP STUDY  
E. Voogt, A. Van Leeuwen, A. Van Der Heide, Rotterdam, The Netherlands
64  QUALITY OF LIFE AND SPIRIUTAL DIMENSION OF PATIENTS WITH ADVANCED CANCER DISEASE  
B. Stelcer, J. Luczak, Poznan, Poland
65  CANCER-RELATED BREAKTHROUGH PAIN: A CASE STUDY   
G. Zeppetella, London, UK
66  SUBLINGUAL FENTANYL FOR BREAKTHROUGH PAIN IN CANCER  
G. Zeppetella, London, UK
67  BREAKTHROUGH PAIN IN NON-CANCER PATIENTS ADMITTED TO A HOSPICE  
G. Zeppetella, C. O'doherty, S. Collins, London, UK
68  SINGLE FRACTION RADIOTHERAPY FOR PAIN FROM BONE METASTASES FOR PATIENTS IN PALLIATIVE HOME CARE SETTINGS   
S. Mak-Kregar, B.J. Slotman, D.L. Willems, Amsterdam, The Netherlands
69  BUPRENORPHINE TRANSDERMAL SYSTEM (TDS) (DELIVERY RATE 35MG/H) IN COMPARISON TO SUBLINGUAL TABLETS IN CHRONIC PAIN PATIENTS 
J. Sorge, Peine, Germany
70  BUPRENORPHINE TRANSDERMAL SYSTEM (TDS) IN AN OPEN LONG-TERM STUDY WITH CHRONIC PAIN PATIENTS  
M. Kopp, Augsburg, Germany
71  ANALGESIC EFFICACY AND SAFETY OF BUPRENORPHINE TTS IN PATIENTS WITH CHRONIC PAIN   
R. Sittl, R. Likar, Erlangen, Germany
72  ADENOSINE INFUSIONS FOR INTRACTABLE NEUROPATHIC PAIN IN PALLIATIVE HOSPICE HOME CARE   
E. Gyllenhammar, L.O. Nordfors, Sollentuna, Sweden
73  THE USE OF TRANSDERMAL FENTANYL (DUROGESIC) IN THE TREATMENT OF CANCER PAIN   
W. Leppert, J. Luczak, L. Gorzelinska, J. Kozikowska, S.P. Wozniak, Poznan, Poland
74  ORAL TRANSMUCOSAL FENTANYL CITRATE (ACTIQ) IN THE MANAGEMENT OF INCIDENT PAIN   
C. Fraser, M. Johnson, M.T. Fallon, UK
75  PREVALENCE OF CLINICALLY RELEVANT SYMPTOMS OF OPIOID TOXICITY IN 50 PATIENTS IN A REGIONAL ONCOLOGY CENTRE   
K. Sherry, M.T. Fallon, Ayr, UK
76  STRONTIUM 89 IN PALLIATIVE THERAPY OF PROSTATIC CANCER BONE METASTASES   
M. Baczyk, P. Milecki, E. Baczyk, J. Sowinski, J. Luczak, Poland
77  EFFECTIVENESS OF STRONTIUM 89 IN TREATMENT OF PAIN ASSOCIATED WITH OSSEOUS METASTASES   E. Nowakowska, P. Milecki, E. Sibilska, G. Bak, G. Stryczynska, J. Luczak, Poland
78  INTRAVENOUS MORPHINE TITRATION IN A CANCER PAIN PATIENT AT HOME - A CASE REPORT   
F. Elsner, R. Sabatowski, L. Radbruch, Koeln, Germany
79  UNCONTROLLABLE PAIN IN THE FINAL STAGE OF CANCER: A CASE REPORT   
K. Pollmann-Daamen, R. Sabatowski, F. Elsner, L. Radbruch, Koeln, Germany
80  INTRAVENOUS VS. SUBCUTANEOUS MORPHINTITRATION IN PATIENTS WITH EXACERBATION OF CHRONIC CANCER PAIN   
G. Loick, L. Radbruch, R. Sabatowski, F. Elsner, M. Oettermann, K.A. Lehmann, Koeln, Germany
81  CHARACTERISTICS OF TERMINAL CANCER PATIENTS WHO COMMITTED SUICIDE DURING A HOME PALLIATIVE CARE PROGRAMME  
C. Ripamonti, A. Filiberti, A. Totis, V. Ventafridda, F. de Conno, M. Tamburini, Milan, Italy
82  WHEN HOSPICE PATIENTS COMMITTED SUICIDE   
P. Ho, R. Yuen, C. Kwan, C. Lai, Hong Kong, China
83  ANALGESIC EFFECT OF LAMOTRAGINE IN NEUROLEUKOSIS   
T. Dolidze, N. Katanjan, Tbilisi, Georgia
84  CRYODENERVATION IN THE PAIN MANAGEMENT OF ADVANCED PANCREATIC CANCER   
O.O. Lytvynenko, S.A. Lyalkin, O.V. Kovalchuk, Ukraine
85  INVASIVE PROCEDURE: A CRITICAL OVERVIEW   
V. Viggiano, F. de Conno, Milan, Italy
86  PAIN EXPERIENCED BY PATIENTS HOSPITALIZED AT THE NATIONAL CANCER INSTITUTE OF MILAN RESEARCH PROJECT "TOWARDS A PAIN-FREE HOSPITAL"   
F. de Conno, E. Zecca, C. Brunelli, L. Groff, R. Boffi, A. Caraceni, G. Galeazzi, C. Martini, C. Panceri, L. Saita, V. Viggiano, C. Ripamonti, Milan, Italy
87  A RANDOMISED , DOUBLE-BLIND, CONTROLLED TRIAL OF HYDROMORPHONE (IMMEDIATE AND SUSTAINED-RELEASE) VERSUS MORPHINE (IMMEDIATE AND SUSTAINED-RELEASE0 IN CANCER PAIN.  
H. Magdi, London, UK
88  SWITCHING FROM MORPHINE TO METHADONE TO IMPROVE ANALGESIA AND TOLERABILITY IN CANCER PATIENTS. A PROSPECTIVE STUDY  
A. Casuccio, L. Groff, R. Boffi, P. Villari, V. Gebbia, C. Ripamonti, S. Mercadante, Italy
89  MORAL PROBLEMS IN PALLIATIVE CARE JOURNALS  
H. Ten Have, R. Janssens, M. Hermsen, The Netherlands
90  QUALITY OF LIFE AND THE CONCEPT OF A LIFE NOT WORTH LIVING  
B. Farsides, London, UK
91  EUTHANASIA AND PHYSICIAN-ASSISTED SUICIDE IN SCANDINAVIA  
L.J. Materstvedt, S. Kaasa, Trondheim, Norway
92  FREQUENCY OF REQUEST FOR EUTHANASIA IN PALLIATIVE CARE UNITS IN RHONE-ALPES AREA (FRANCE)  
M. Comby, M. Filbet Lyon, Aut, France
93  BREAKING OFF THERAPY AND THERAPY REFUSAL IN AN ONCOLOGICAL PALLIATIVE CARE UNIT  
B. Van Oorschot, S.M. Liesenfeld, T.G. Wendt, Jena, Germany
94  PALLIATIVE CARE AT HOME: VIEWS OF PATIENTS AND CARERS ON A GOOD DEATH  
G.A.M. Widdershoven, M.J. Smits, I. Proot, Maastricht, The Netherlands
95  WHAT DO UNDERGRADUATE NURSES LEARN ABOUT PALLIATIVE CARE?   
M. Lloyd-Williams, Leicester , UK
96  PAIN AND SYMPTOM MANAGEMENT IN PALLIATIVE CARE: A PRACTICAL GUIDE   
J. Swinkels, A. Kenis, Keerbergen, Belgium
97  PALLIATIVE CARE FOR PATIENTS WITH ADVANCED LUNG CANCER- MULTIDISCIPLINARY APROACH   
S.P. Wozniak, W. Leppert, J. Luczak, Wroclaw, Poland
98  THE ROLE OF MULTIDISCIPLINARY TEAM IN PALLIATIVE CARE FOR PATIENTS WITH METASTATIC BREAST CANCER  
S.P. Wozniak, B. Stelcer, A. Oronska, J. Luczak, E. Mess, A. Leppert, Wroclaw, Poland
99  EXPANDING TREATMENT IN PALLIATIVE MEDICINE: THE USE OF MUSIC THERAPY TO IMPROVE MOOD   
J. Homsi, L.M. Gallagher, K. Nelson, D. Walsh, L. Steele, USA
100  A SURVEY ON THE USE OF ALTERNATIVE MEDICINE BY NEUROLOGICAL PALLIATIVE PATIENTS   
M. Wasner, H. Klier, G.D. Borasio, Munich, Germany
101  EFFECT OF AROMATHERAPY IN DAY HOSPICE  
C. Ip, N. Ngan, B. Tam, Hong Kong, China
102  ENDOSCOPIC LASER ABLATION AS PALLIATIVE TREATMENT OF ENDOBRONCHIAL, NON-RESECTABLE OR RECURRENT LUNG CANCER: ASSESSMENT OF ITS IMPACT ON QUALITY OF LIFE
G. Mantovani, G. Astara, G. Manca, R. Versace, P. Contu, A. Carai, Cagliari, Italy
103  PROBLEMS AND PRACTICALITIES OF EVIDENCE-BASED MEDICINE (EBM) IN PALLIATIVE MEDICINE: EXPERIENCES OF REVIEWING LITERATURE ABOUT CLINICAL ESTIMATION OF SURVIVAL   
S. Eychmueller, P. Glare, N. Christakis, St-Gallen, Switzerland
104  A DIAGNOSTIC "TOOLKIT" FOR PROGNOSTICATION IN PATIENTS WITH ADVANCED CANCER   
K. Virik, P. Glare, Australia
105  PALLIATIVE MEDICINE IN UK UNDERGRADUATE EDUCATION   
G.W. Hanks, K. Forbes, UK
106  ARE GUIDELINES FOR THE USE OF DRUGS FOR SYMPTOM CONTROL IN PALLIATIVE CARE BEING USED BY GP REGISTRARS?   
C. Hirsch, C. Faull, S. Field, R. Charlton, UK
107  CANCER PATIENTS IN THE PALLIATIVE PHASE DO WANT TO PARTICIPATE IN RESEARCH!   
M.J. Hoekstra, N.P. Van Duijn, Amsterdam, The Netherlands
108  A NEW MODEL OF PSYCHOSOCIAL CARE FOR CANCER PATIENTS IN BELGIUM   
S. Bauwens, W. Distelmans, Brussels, Belgium
109  QUALITY OF CARE IN A PALLIATIVE NETWORK  
T. Van Iersel, A. Mullie, Brugge, Belgium
110  MORPHINE CONSUMPTION IN HOSPICE AND HOSPITALS OF FRIULI VENEZIA GIULIA (ITALY)  
R. Bortolussi, S. Spazzapan, M. Matovic, L. Plai, Aviano , Italy
111  WHAT DO EUROPEAN ONCOLOGISTS KNOW AND PRACTICE ABOUT PAIN CONTROL?   
S.H. Ahmedzai, A.S. Lubbe, B. Van Den Eynden, Sheffield , UK
112  WHAT ARE THE GENUINE NEEDS OF ADVANCED CANCER PATIENTS?   
R. Yuen, S. Lui, Hong Kong, China 

top


©Designed by